Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Dan Moldoveanu"'
Autor:
Christina Dilaveri, Amy Degnim, Christine Lee, Daniel DeSimone, Dan Moldoveanu, Karthik Ghosh
Publikováno v:
The Breast Journal, Vol 2024 (2024)
Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory disorder of the breast that is often underrecognized. The exact etiology and pathophysiology are unknown, but milk stasis is felt to play a role. Classically, this condition is no
Externí odkaz:
https://doaj.org/article/cbda2ecb704a475d987ae8c92a20beb4
Autor:
Dan, Moldoveanu, Ericka, Iny, Chloe, Theriault, Anca, Florea, Stephanie M, Wong, Mark, Basik, Jean-François, Boileau, Richard, Margolese, Manuela, Pelmus, Sarkis, Meterissian, Ipshita, Prakash
Publikováno v:
Annals of Surgical Oncology. 30:1700-1709
Phyllodes tumours of the breast are rare fibroepithelial neoplasms with a propensity for recurrence. While surgical excision remains the standard of care, the optimal margin width is an area of active investigation. Recent studies have questioned the
Autor:
April A.N. Rose, Peter M. Siegel, Ian R. Watson, Catalin Mihalcioiu, Kevin Petrecca, Marie-Christine Guiot, Morag Park, David Hogg, Dana Vuzman, Alexei Protopopov, Maria Lvova, Xiu Huang, Shivshankari Rajkumar, Paul Savage, Tan-Trieu Nguyen, Dan Moldoveanu, Mathieu Lajoie, Matthew Dankner
Supplementary legends and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf0ab7e2694ea4d1ff168fefc70087b
https://doi.org/10.1158/1078-0432.22470732.v1
https://doi.org/10.1158/1078-0432.22470732.v1
Autor:
April A.N. Rose, Peter M. Siegel, Ian R. Watson, Catalin Mihalcioiu, Kevin Petrecca, Marie-Christine Guiot, Morag Park, David Hogg, Dana Vuzman, Alexei Protopopov, Maria Lvova, Xiu Huang, Shivshankari Rajkumar, Paul Savage, Tan-Trieu Nguyen, Dan Moldoveanu, Mathieu Lajoie, Matthew Dankner
FIGURE S1: LY3009120 is an effective inhibitor of BRAF class II mutant melanoma cells. FIGURE S2: Bioinformatic characterization of PDX models. FIGURE S3: Inhibitory effects of BRAF and MEK inhibitors in melanoma cells. FIGURE S4: Representative imag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b882b026c73f1304af83d44b5d5c5efd
https://doi.org/10.1158/1078-0432.22470735
https://doi.org/10.1158/1078-0432.22470735
Autor:
April A.N. Rose, Peter M. Siegel, Ian R. Watson, Catalin Mihalcioiu, Kevin Petrecca, Marie-Christine Guiot, Morag Park, David Hogg, Dana Vuzman, Alexei Protopopov, Maria Lvova, Xiu Huang, Shivshankari Rajkumar, Paul Savage, Tan-Trieu Nguyen, Dan Moldoveanu, Mathieu Lajoie, Matthew Dankner
Purpose:Dual MAPK pathway inhibition (dMAPKi) with BRAF and MEK inhibitors improves survival in BRAF V600E/K mutant melanoma, but the efficacy of dMAPKi in non-V600 BRAF mutant tumors is poorly understood. We sought to characterize the responsiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6671f441118fea64167c24174734747e
https://doi.org/10.1158/1078-0432.c.6527670.v1
https://doi.org/10.1158/1078-0432.c.6527670.v1
Publikováno v:
Journal of Surgical Case Reports. 2022
Locally advanced breast cancer arising from ectopic axillary breast tissue is an unusual presentation of this malignancy. The work-up and treatment approach pose some unique challenges. We present the case of a 37-year-old female presenting with a le
Autor:
Dan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie, Luke Anderson-Trocme, Marine Lingrand, Diana Berry, Lucas J.M. Perus, Yuhong Wei, Cleber Moraes, Rached Alkallas, Shivshankari Rajkumar, Dongmei Zuo, Matthew Dankner, Eric Hongbo Xu, Nicholas R. Bertos, Hamed S. Najafabadi, Simon Gravel, Santiago Costantino, Martin J. Richer, Amanda W. Lund, Sonia V. Del Rincon, Alan Spatz, Wilson H. Miller, Rahima Jamal, Réjean Lapointe, Anne-Marie Mes-Masson, Simon Turcotte, Kevin Petrecca, Sinziana Dumitra, Ari-Nareg Meguerditchian, Keith Richardson, Francine Tremblay, Beatrice Wang, May Chergui, Marie-Christine Guiot, Kevin Watters, John Stagg, Daniela F. Quail, Catalin Mihalcioiu, Sarkis Meterissian, Ian R. Watson
Publikováno v:
Science Immunology. 7
Melanoma is an immunogenic cancer with a high response rate to immune checkpoint inhibitors (ICIs). It harbors a high mutation burden compared with other cancers and, as a result, has abundant tumor-infiltrating lymphocytes (TILs) within its microenv
Autor:
Gordie Best, Ari N. Meguerditchian, Ian Watson, Sinziana Dumitra, Mathieu Lajoie, Dan Moldoveanu, Constanza Martínez, Sarkis Meterissian, Tarek Hijal, Vera Pravongviengkham
Publikováno v:
Annals of Surgical Oncology. 27:4028-4034
The neutrophil-to-lymphocyte ratio (NLR) is a measure of systemic inflammation and a prognostic factor for multiple malignancies. This study assesses the value of the NLR as an independent prognostic marker in triple-negative breast cancer (TNBC) and
Publikováno v:
Cancer Research. 83:P6-01
Background: The role of chemotherapy in node positive (N+) luminal breast cancer (BC) is often debated, given low total pathologic complete response (pCR) rates following neoadjuvant chemotherapy (NAC) and discrepancy in adjuvant chemotherapy benefit
Autor:
Dan Moldoveanu, Ericka Iny, Chloe Theriault, Anca Florea, Stephanie M. Wong, Mark Basik, Jean-François Boileau, Richard Margolese, Manuela Pelmus, Sarkis Meterissian, Ipshita Prakash
Publikováno v:
Annals of Surgical Oncology. 30:3280-3280